Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 7594805, 12 pages
https://doi.org/10.1155/2017/7594805
Research Article

Identification of Tengfu Jiangya Tablet Target Biomarkers with Quantitative Proteomic Technique

1Shandong University of Traditional Chinese Medicine, 4655 Daxue Road, Changqing District, Jinan, Shandong, China
2Affiliated Hospital of Shandong University of Traditional Chinese Medicine, 16369 Jingshi Road, Lixia District, Jinan, Shandong, China
3Affiliated Hospital of Shandong Academy of Medical Sciences, 38 Shadowless Hill Road, Tianqiao District, Jinan, Shandong, China
4Shandong Tumor Hospital, 440 Jiyan Road, Jinan, Huaiyin District, Shandong, China

Correspondence should be addressed to Yunlun Li

Received 14 October 2016; Accepted 8 February 2017; Published 20 March 2017

Academic Editor: Dolores García Giménez

Copyright © 2017 Jingwen Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. D. Pierdomenico, M. Di Nicola, A. L. Esposito et al., “Prognostic value of different indices of blood pressure variability in hypertensive patients,” American Journal of Hypertension, vol. 22, no. 8, pp. 842–847, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Mancia, S. Laurent, E. Agabiti-Rosei et al., “Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force documental,” Blood Pressure, vol. 18, no. 6, pp. 308–347, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. Writing Group of 2010 Chinese Guidelines for the Management of Hypertension, “2010 Chinese guidelines for the management of hypertension,” Zhonghua Xin Xue Guan Bing Za Zhi, vol. 39, pp. 579–615, 2011. View at Google Scholar
  4. B. M. Schmidt, D. M. Ribnicky, P. E. Lipsky, and I. Raskin, “Revisiting the ancient concept of botanical therapeutics,” Nature Chemical Biology, vol. 3, no. 7, pp. 360–366, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Jiang, Z. Shen, Y. Chu et al., “Serum metabolomics research of the anti-hypertensive effects of Tengfu Jiangya tablet on spontaneously hypertensive rats,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 1002, pp. 210–217, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. Z. Shi, Z. Lu, Y. Zhao et al., “Neuroprotective effects of aqueous extracts of Uncaria tomentosa: insights from 6-OHDA induced cell damage and transgenic Caenorhabditis elegans model,” Neurochemistry International, vol. 62, no. 7, pp. 940–947, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Li, W. Yang, Q. Zhu, J. Yang, and Z. Wang, “Protective effects on vascular endothelial cell in N'-nitro-L-arginine (L-NNA)-induced hypertensive rats from the combination of effective components of Uncaria rhynchophylla and Semen Raphani,” BioScience Trends, vol. 9, no. 4, pp. 237–244, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. L. Li, M. Zhu, D. B. Cheng, and H. Q. Jiang, “Effect of Tengfu Jiangya Capsules on rat with hypertension,” Chinese Traditional Patent Medicine, vol. 35, pp. 2581–2586, 2013. View at Google Scholar
  9. L. E. Hood, G. S. Omenn, R. L. Moritz et al., “New and improved proteomics technologies for understanding complex biological systems: addressing a grand challenge in the life sciences,” Proteomics, vol. 12, no. 18, pp. 2773–2783, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Matt, Z. M. Fu, Q. Fu, and J. E. Van Eyk, “Biomarker discovery: proteome fractionation and separation in biological samples,” Physiological Genomics, vol. 33, no. 1, pp. 12–17, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Cao, Y. Zhou, Y. Li et al., “iTRAQ-based proteomic analysis of combination therapy with taurine, epigallocatechin gallate, and genistein on carbon tetrachloride-induced liver fibrosis in rats,” Toxicology Letters, vol. 232, no. 1, pp. 233–245, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. N. I. Govorukhina, M. de Vries, T. H. Reijmers, P. Horvatovich, A. G. J. van der Zee, and R. Bischoff, “Influence of clotting time on the protein composition of serum samples based on LC-MS data,” Journal of Chromatography B, vol. 877, no. 13, pp. 1281–1291, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. L. V. DeSouza, J. Grigull, S. Ghanny et al., “Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry,” Molecular and Cellular Proteomics, vol. 6, no. 7, pp. 1170–1182, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Ralhan, L. V. DeSouza, A. Matta et al., “Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry,” Molecular and Cellular Proteomics, vol. 7, no. 6, pp. 1162–1173, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. K. M. Redding, B. L. Chen, A. Singh et al., “Transgenic mice expressing an intracellular fluorescent fusion of angiotensin II demonstrate renal thrombotic microangiopathy and elevated blood pressure,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 298, no. 6, pp. H1807–H1818, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. D.-D. Xu, D.-F. Deng, X. Li et al., “Discovery and identification of serum potential biomarkers for pulmonary tuberculosis using iTRAQ-coupled two-dimensional LC-MS/MS,” Proteomics, vol. 14, no. 2-3, pp. 322–331, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Kato, K.-I. Enjyoji, T. Miyata, I. Hayashi, S. Ohishi, and S. Iwanaga, “Demonstration of arginyl-bradykinin moiety in rat HMW kininogen: direct evidence for liberation of bradykinin by rat glandular kallikreins,” Biochemical and Biophysical Research Communications, vol. 127, no. 1, pp. 289–295, 1985. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Scharfstein, V. Schmitz, E. Svensjö, A. Granato, and A. C. Monteiro, “Kininogens coordinate adaptive immunity through the proteolytic release of bradykinin, an endogenous danger signal driving dendritic cell maturation,” Scandinavian Journal of Immunology, vol. 66, no. 2-3, pp. 128–136, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. E. G. Schneider, J. W. Strandhoy, L. R. Willis, and F. G. Knox, “Relationship between proximal sodium reabsorption and excretion of calcium, magnesium and phosphate,” Kidney International, vol. 4, no. 6, pp. 369–376, 1973. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Katori and M. Majima, “The renal kallikrein-kinin system: its role as a safety valve for excess sodium intake, and its attenuation as a possible etiologic factor in salt-sensitive hypertension,” Critical Reviews in Clinical Laboratory Sciences, vol. 40, no. 1, pp. 43–115, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Remotti, J. F. Fetsch, and M. Miettinen, “Keratin 1 expression in endothelia and mesenchymal tumors: an immunohistochemical analysis of normal and neoplastic tissues,” Human Pathology, vol. 32, no. 8, pp. 873–879, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. A. A. K. Hasan, T. Zisman, and A. H. Schmaier, “Identification of cytokeratin 1 as a binding protein and presentation receptor for kininogens on endothelial cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 7, pp. 3615–3620, 1998. View at Publisher · View at Google Scholar · View at Scopus
  23. U. Jerke, S. Rolle, B. Purfürst, F. C. Luft, W. M. Nauseef, and R. Kettritz, “β2 integrin-mediated cell-cell contact transfers active myeloperoxidase from neutrophils to endothelial cells,” Journal of Biological Chemistry, vol. 288, no. 18, pp. 12910–12919, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. J. Yang, G. A. Preston, W. F. Pendergraft et al., “Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants,” American Journal of Pathology, vol. 158, no. 2, pp. 581–592, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Xiao, P. Heeringa, P. Hu et al., “Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice,” Journal of Clinical Investigation, vol. 110, no. 7, pp. 955–963, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. A. E. Walker, S. M. Seibert, A. J. Donato, G. L. Pierce, and D. R. Seals, “Vascular endothelial function is related to white blood cell count and myeloperoxidase among healthy middle-aged and older adults,” Hypertension, vol. 55, no. 2, pp. 363–369, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. J. M. Astern, W. F. Pendergraft III, R. J. Falk et al., “Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma kallikrein-kinin system,” The American Journal of Pathology, vol. 171, no. 1, pp. 349–360, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. D. R. Soprano, K. J. Soprano, and D. S. Goodman, “Retinol-binding protein messenger RNA levels in the liver and in extrahepatic tissues of the rat,” Journal of Lipid Research, vol. 27, no. 2, pp. 166–171, 1986. View at Google Scholar · View at Scopus
  29. A. Solini, E. Santini, S. Madec, C. Rossi, and E. Muscelli, “Retinol-binding protein-4 in women with untreated essential hypertension,” American Journal of Hypertension, vol. 22, no. 9, pp. 1001–1006, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. K. M. Farjo, R. A. Farjo, S. Halsey, G. Moiseyev, and J.-X. Ma, “Retinol-binding protein 4 induces inflammation in human endothelial cells by an NADPH oxidase- and nuclear factor kappa B-dependent and retinol-independent mechanism,” Molecular and Cellular Biology, vol. 32, no. 24, pp. 5103–5115, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Sjöholm, J. Palming, L. E. Olofsson et al., “A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 4, pp. 2233–2239, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. U. N. Das, “Is angiotensin-II an endogenous pro-inflammatory molecule?” Medical Science Monitor, vol. 11, no. 5, pp. RA155–RA162, 2005. View at Google Scholar · View at Scopus
  33. Y. Qi, A. Rathinasabapathy, T. Huo et al., “Dysfunctional adipose stem cell is linked to obesity, elevated inflammatory cytokines and resistant hypertension,” Journal of Hypertension, vol. 33, no. 1, article e90, 2015. View at Publisher · View at Google Scholar